vimarsana.com
Home
Live Updates
MEI Pharma Board of Directors Aligns on Strategy to Advance
MEI Pharma Board of Directors Aligns on Strategy to Advance
MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital,...
Related Keywords
Taheer Datoo ,
David Urso ,
Company Board Of Directors ,
Linkedin ,
Nasdaq ,
Pharma Inc ,
Cable Car Capital ,
Anson Funds ,
Clinical Study ,
Markets ,